Anna Dodero

2.6k total citations
73 papers, 1.7k citations indexed

About

Anna Dodero is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Anna Dodero has authored 73 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 40 papers in Pathology and Forensic Medicine and 27 papers in Immunology. Recurrent topics in Anna Dodero's work include Lymphoma Diagnosis and Treatment (40 papers), CAR-T cell therapy research (23 papers) and Hematopoietic Stem Cell Transplantation (18 papers). Anna Dodero is often cited by papers focused on Lymphoma Diagnosis and Treatment (40 papers), CAR-T cell therapy research (23 papers) and Hematopoietic Stem Cell Transplantation (18 papers). Anna Dodero collaborates with scholars based in Italy, United Kingdom and United States. Anna Dodero's co-authors include Paolo Corradini, Alessandro Rambaldi, Corrado Tarella, Alessandro M. Gianni, Marco Bregni, Francesco Zallio, Francesca Patriarca, Fabio Benedetti, Lucia Farina and Franco Narni and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Anna Dodero

68 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Dodero Italy 21 948 898 695 561 270 73 1.7k
Francesco Zallio Italy 18 853 0.9× 682 0.8× 400 0.6× 401 0.7× 243 0.9× 41 1.3k
Yasushi Isobe Japan 20 1.1k 1.2× 1.1k 1.2× 692 1.0× 207 0.4× 229 0.8× 56 1.6k
E. Condé Spain 21 1.1k 1.2× 943 1.1× 314 0.5× 284 0.5× 452 1.7× 43 1.7k
Tycel Phillips United States 22 956 1.0× 899 1.0× 367 0.5× 278 0.5× 554 2.1× 149 1.6k
Alessandra Pucciarini Italy 14 691 0.7× 413 0.5× 345 0.5× 359 0.6× 413 1.5× 19 1.4k
P. M. Kluin Netherlands 21 1.0k 1.1× 797 0.9× 314 0.5× 260 0.5× 431 1.6× 40 1.8k
Kenkichi Kita Japan 18 622 0.7× 559 0.6× 434 0.6× 325 0.6× 276 1.0× 57 1.2k
Andy I. Chen United States 14 829 0.9× 797 0.9× 552 0.8× 140 0.2× 278 1.0× 38 1.5k
Jeanette Lundin Sweden 21 1.1k 1.2× 544 0.6× 1.1k 1.5× 448 0.8× 1.1k 4.1× 53 2.2k
CM Spier United States 12 915 1.0× 716 0.8× 326 0.5× 312 0.6× 378 1.4× 15 1.5k

Countries citing papers authored by Anna Dodero

Since Specialization
Citations

This map shows the geographic impact of Anna Dodero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Dodero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Dodero more than expected).

Fields of papers citing papers by Anna Dodero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Dodero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Dodero. The network helps show where Anna Dodero may publish in the future.

Co-authorship network of co-authors of Anna Dodero

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Dodero. A scholar is included among the top collaborators of Anna Dodero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Dodero. Anna Dodero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Magni, Martina, Annalisa Chiappella, Anna Dodero, et al.. (2024). Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas. British Journal of Haematology. 204(5). 1752–1756. 1 indexed citations
2.
Magni, Martina, Silva Ljevar, Annalisa Chiappella, et al.. (2022). Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma. Clinical Cancer Research. 28(15). 3378–3386. 35 indexed citations
3.
Carniti, Cristiana, Martina Magni, Anna Dodero, et al.. (2021). Tisagenlecleucel and Axicabtagene Ciloleucel Expansion Kinetics and CAR T Cell Attributes in the Infusion Products Are Early Predictors of Clinical Efficacy. Blood. 138(Supplement 1). 3877–3877. 2 indexed citations
4.
Mussetti, Alberto, et al.. (2018). Real-life feasibility of salvage allogeneic transplantation in peripheral T-cell lymphomas. Bone Marrow Transplantation. 54(8). 1237–1244. 4 indexed citations
5.
Maura, Francesco, Anna Dodero, Cristiana Carniti, & Niccolò Bolli. (2016). Biology of peripheral T cell lymphomas – Not otherwise specified: Is something finally happening?. Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano). 3(1). 9–18. 10 indexed citations
6.
Guidetti, Anna, Carmelo Carlo‐Stella, Silvia L. Locatelli, et al.. (2014). Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases. Clinical Cancer Research. 20(22). 5641–5651. 27 indexed citations
7.
Mariotti, Jacopo, Francesco Maura, Francesco Spina, et al.. (2014). Impact of Cytomegalovirus Replication and Cytomegalovirus Serostatus on the Outcome of Patients with B Cell Lymphoma after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(6). 885–890. 32 indexed citations
8.
Montefusco, Vittorio, Mónica Galli, Francesco Spina, et al.. (2014). Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide. Leukemia & lymphoma. 55(9). 2032–2037. 16 indexed citations
9.
Farina, Lucia, Francesco Spina, Anna Guidetti, et al.. (2013). Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor: an algorithm for the pre-emptive use of plerixafor. Leukemia & lymphoma. 55(2). 331–336. 20 indexed citations
10.
Guidetti, Anna, Carmelo Carlo‐Stella, Silvia L. Locatelli, et al.. (2012). Phase II study of sorafenib in patients with relapsed or refractory lymphoma. British Journal of Haematology. 158(1). 108–119. 38 indexed citations
11.
Montefusco, Vittorio, Francesco Spina, Francesca Patriarca, et al.. (2012). Bortezomib Plus Dexamethasone Followed by Escalating Donor Lymphocyte Infusions for Patients with Multiple Myeloma Relapsing or Progressing after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 19(3). 424–428. 21 indexed citations
12.
Milazzo, Laura, Mario Corbellino, Antonella Foschi, et al.. (2011). Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy. Transplant Infectious Disease. 14(1). 95–98. 15 indexed citations
13.
14.
15.
16.
Corradini, Paolo, Lucia Farina, & Anna Dodero. (2007). Hematopoietic stem cell transplantation in peripheral T-cell lymphomas. Leukemia & lymphoma. 48(8). 1496–1501. 8 indexed citations
17.
Dodero, Anna, Matteo Giovanni Carrabba, Raffaella Milani, et al.. (2005). Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed. Experimental Hematology. 33(8). 920–927. 32 indexed citations
18.
Cocconi, Giorgio, Vittorio Franciosi, Anna Dodero, et al.. (2003). P-CHOP: Cisplatin (P) Added to the Standard CHOP Regimen as First-Line Treatment for Aggressive Non-Hodgkin Lymphoma. American Journal of Clinical Oncology. 26(6). 535–542. 1 indexed citations
19.
Bregni, Marco, Anna Dodero, Jacopo Peccatori, et al.. (2002). Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. Blood. 99(11). 4234–4236. 159 indexed citations
20.
Bregni, Marco, Salvatore Siena, Massimo Di Nicola, et al.. (1996). Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.. Journal of Clinical Oncology. 14(2). 628–635. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Zallio Breakdown of academic impact, for papers by Yasushi Isobe Breakdown of academic impact, for papers by E. Condé Breakdown of academic impact, for papers by Tycel Phillips Breakdown of academic impact, for papers by Alessandra Pucciarini Breakdown of academic impact, for papers by P. M. Kluin Breakdown of academic impact, for papers by Kenkichi Kita Breakdown of academic impact, for papers by Andy I. Chen Breakdown of academic impact, for papers by Jeanette Lundin Breakdown of academic impact, for papers by CM Spier
Rankless by CCL
2026